×

收藏-健康网会员访问记录

网页标题:
×

注册健康网用户

用 户 名:
联 系 人:
性  别:
密  码:
重复密码:
电子邮箱:
邮箱验证码:
固定电话:
传  真:
手  机:
单位名称:
通信地址:
首选栏目:
我已经认真阅读并同意《健康网服务条款》
×

找回密码

  • 1.选择找回方式
  • 2.确认验证信息
  • 3.修改密码
  • 4.修改成功
  • 找回方式:
  • 用 户 名:
  • 手机号码:

 您现在位置:健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Hemostatic Drugs and Hemocoagulase Report

作者:wangchun   来源:本站原创    点击数:0    更新时间:2006-11-27 18:25:43

[关键字]: Hemostatic Drugs Hemocoagulase

健康网讯:

Market Research Report on Hemostatic Drugs and Hemocoagulase
Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: 
Format:  Hardcopy and Adobe PDF 
Price:  US$1,960
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68012929-2008
E-mail: bianch@healthoo.com   wuhf@healthoo.com 

The table of contents 
1 Categories and action mechanisms of Hemostatic Drugs
2 Market status of Hemostatic Drugs
  2.1 Theoretical market capacity
  2.2 Sales trend in the past 7 years
  2.3 Market shares of different categories in 2004
  2.4 Top breeds ranked by sales value
  2.5 Leading enterprises
3 Development and application of Hemocoagulase(Batroxobin)
  3.1 Overview of Hemocoagulase
  3.2 Progress of research and development
  3.3 Characteristic of molecule structure of Hemocoagulase
  3.4 Chemical properties of Hemocoagulase
  3.5 Pharmacologic action of Hemocoagulase
  3.6 Clinic usages of Hemocoagulase
4 Sales analysis of Hemocoagulase and Reptilase
  4.1 Sales analysis of hospital market of Hemocoagulase
     4.1.1 General sales trend
     4.1.2 Competing enterprises and region distribution
  4.2 Market share comparison  of Reptilase and BaQuTing(a kind of
 Hemocoagulase)
  4.3 Import status of Reptilase
  4.4 Marketing status of Reptilase and BaQuTing
  4.5 Overview of Reptilase in global market
5 Brief introduction of BaQuTing
6 Brief introduction of Snake Venom Enzyme of BaiMei Pallas Pit Viper 
(marketed by Jingzhou ChiTai biological company)
7 Brief introduction of "ZhiXieSu"(a kind of Hemocoagulase)
8 Slaes analysis of Aprotinin
  8.1 Brief introduction of Aprotinin
  8.2 Sales status of Aprotinin in hospital market
  8.3 Competing enterprises and region distribution
9 Enterprise shares of other Hemostatic Drugs
  9.1 Competing enterprises of tranexamic acid
  9.2 Competing enterprises of prothrombin complex
  9.3 Competing enterprises of thrombin
  9.4 Competing enterprises of human fibrinogen
  9.5 Competing enterprises of Carbazochrome
  9.6 Competing enterprises of Aminomethylbenzoic Acid
  9.7 Competing enterprises of Etamsylate
Hemostatic Drugs and Hemocoagulase Report
注册后,我们会为你提供报告样本并为您提供更全面的咨询服务
您的姓名  称谓: 先生女士
手机号码 
电子邮件 
单位名称 

服务热线

  • 联系项目:86-10-68012929-2103
  • 订购报告:86-10-68012929-2103
  • 邮件订购:leigy@healthoo.com